Thomson D M, Gold P, Freedman S O, Shuster J
Cancer Res. 1976 Sep;36(9 PT 2):3518-25.
Putative tumor-specific transplantation antigens (TSTA) from both a carcinogen-induced rodent tumor (MC-1) and 2 human tumors were purified. The antigens were solubilized from the tumor cell membranes by limited papain digestion in a manner similar to that described for the isolation of normal histocompatibility antigens. The antitumor immune response of the tumor-bearing host was used to monitor the purification of the putative TSTA in both the rodent and human tumor systems. In the case of the rodent tumor, a major step in the purification of the TSTA involved affinity chromatography on Sepharose beads coupled to autologous antitumor antiserum. A comparable procedure was utilized in the purification of the TSTA from human tumors by using affinity chromatography on anti-human beta2-microglobulin antiserum coupled to a solid phase. The data obtained indicate that the TSTA of human tumors contains a beta2-microglobulin chain that is immunochemically identical with, and very similar in size to, that found in normal human histocompatibility antigens. A subunit of similar size was also identified in the carcinogen-induced rodent tumor. These results suggest that the TSTA in both humans and rodents may well be altered histocompatibility antigens.
从致癌物诱导的啮齿动物肿瘤(MC-1)和两种人类肿瘤中纯化出了假定的肿瘤特异性移植抗原(TSTA)。通过有限的木瓜蛋白酶消化从肿瘤细胞膜中溶解抗原,其方式类似于分离正常组织相容性抗原时所描述的方法。利用荷瘤宿主的抗肿瘤免疫反应来监测啮齿动物和人类肿瘤系统中假定TSTA的纯化过程。对于啮齿动物肿瘤,TSTA纯化的一个主要步骤涉及在与自体抗肿瘤抗血清偶联的琼脂糖珠上进行亲和层析。通过在与固相偶联的抗人β2-微球蛋白抗血清上进行亲和层析,采用了类似的方法来纯化人类肿瘤中的TSTA。所获得的数据表明,人类肿瘤的TSTA含有一条β2-微球蛋白链,其免疫化学性质与正常人类组织相容性抗原中的β2-微球蛋白链相同,大小也非常相似。在致癌物诱导的啮齿动物肿瘤中也鉴定出了大小相似的一个亚基。这些结果表明,人类和啮齿动物中的TSTA很可能是改变了的组织相容性抗原。